C4 Therapeutics, Inc. (CCCC) Cash Flow Annual - Discounting Cash Flows
C4 Therapeutics, Inc.
CCCC (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
Report Filing: 2025-05-07 2025-02-27 2024-02-22 2023-02-23 2022-02-24 2021-03-11 2019-12-31 2018-12-31
Net Income/Starting Line -103.3 -105.3 -132.5 -128.2 -83.89 -66.33 -34.1 -15.71
Cash From Operating Activities -80.32 -65.16 -106.8 -105.9 -86.97 -67.25 55.61 -16.98
Depreciation and Amortization -1.35 1.82 1.88 1.68 1.49 1.62 1.59 1.27
Deferred Income Tax 0 0 0 0 1.88 5.58 0.35 0.066
Stock Based Compensation 28.95 29.66 27.23 30.02 21.51 3.43 1.64 0.582
Other Non-Cash Items 5.1 1.03 3.48 7.32 2.13 1.63 1.14 2.37
Changes in Working Capital -9.75 7.65 -6.94 -16.78 -30.09 -13.18 84.98 -5.56
Accounts Receivable 5.57 8.7 -10.33 4.24 -1.23 0.139 81.81 -84.94
Inventory 0 0 0 0 -2.63 -1.58 2.17 -2.22
Accounts Payable -0.946 -0.119 0.273 -3.33 -1.18 0.467 4.23 0.578
Deferred Revenue -14.38 -0.93 3.12 -17.69 -25.05 -12.2 -3.23 81.03
Other Working Capital 0 0 0 0 0 0 0 0
Cash From Investing Activities 31.25 -51.27 158.3 58.42 -189.3 -190.5 -1.62 36.92
Investments in Property Plant and Equipment -0.18 -0.18 -1.71 -5.5 -1.28 -0.65 -1.35 -2.69
Payments for Acquisitions 0 0 0 -63.92 188.1 189.9 0.063 0
Purchases of Securities -202.2 -284.3 -129.9 -219.5 -537.7 -293.9 -79 -4.99
Sales and Maturities of Investments 233.6 233.2 290 283.4 349.7 104 78.67 44.6
Other Investing Activities -11.51 0 0 63.92 -188.1 -189.9 -0.271 39.61
Cash From Financing Activities 10.71 45.34 45.49 1.15 171.4 348.9 0.244 1.96
Debt Repayment 0 0 -12.5 0 0 11.97 0 0
Common Stock Issued 10.42 44.37 57.67 0.777 169.5 340.6 0 0.047
Common Stock Repurchased -0.24 -0.194 -0.11 0 0 -0.194 -0.03 -0.063
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities 0.542 1.16 0.426 1.15 1.94 -3.45 0.274 1.91
Effect of Forex Changes on Cash 0 0 0 0 0 0 0 0
Net Change in Cash -18.38 -71.09 97 -46.37 -104.9 91.18 54.24 21.9
Cash at Beginning of Period 73.11 130 33.03 79.4 184.3 93.13 38.89 16.99
Cash at End of Period 54.74 58.94 130 33.03 79.4 184.3 93.13 38.89
Free Cash Flow -80.5 -65.34 -108.5 -111.4 -88.24 -67.9 54.27 -19.67
Operating Cash Flow -80.32 -65.16 -106.8 -105.9 -86.97 -67.25 55.61 -16.98
Capital Expenditure -0.18 -0.18 -1.71 -5.5 -1.28 -0.65 -1.35 -2.69
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us